OECD Home › Science and technology › Publications & Documents › Meetings / Conferences / Agendas
Meetings / Conferences / Agendas
This workshop provided a forum for exchanges of experience and mutual learning on best practices in some OECD countries and the current S&T indicator system in China.
Proceedings of an international workshop to assess the causes behind the low participation of women in scientific careers, especially at senior levels, and to identify good practice policies to attract, recruit and retain women in scientific careers in public and private research.
The main objectives of the workshop were: i) to discuss the history and evolution of the conceptual framework for the evaluation of transgenic plant products in the environment and OECD’s role in the development of that framework; ii) to discuss the current contribution of OECD’s Working Group for the Harmonization of Regulatory Oversight in Biotechnology to risk/ safety assessment practice; and iii) to discuss current risk assessment
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
English, , 1,610kb
The objective of the workshop was to identify and review the kinds of baseline information of (non-transgenic) traditional fish farming or breeding, and to determine what information might be relevant to risk/ safety assessment.
The Blue Sky II Forum in Ottawa on 25-27 September 2006 will examine new areas for indicator development and set a broad agenda for future work on science, technology and innovation (STI) indicators.
This joint OECD-Spanish government workshop on "Researcher Careers for the 21st Century" aimed to address key issues on researcher careers. A summary of the workshop is available here.
The initiative for this workshop grew from an idea launched by France’s Mission for Gender Equality in Research and Higher Education, following a conference bringing together OECD Ministers of Research in January 2004.
This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.
The main objective of the Workshop on the Safety of Manufactured Nanomaterials was to determine the “state-of–the–art” for the safety assessment of manufactured nanomaterials with a particular focus on identifying future needs for risk assessment within a regulatory context.